GGrantIndex
← Leaderboards

Teresa R Franklin

University Of Pennsylvania

$4,425,553
Attributed
$4,425,553
Total exposure
8
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $696.6K · FY200517
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17

Funding mix

By agency

NIH$4,425,553 · 8

By mechanism

R01$3,711,226 · 3
R21$344,925 · 1
K01$335,842 · 1
M01$17,200 · 1
P41$16,360 · 2

Top collaborators

No co-investigators on record.

Most similar at University Of Pennsylvania

Same institution · by research overlap

Others in their field

Top investigators on “Functional Magnetic Resonance Imaging

Research focus

Functional Magnetic Resonance ImagingSmokingCuesSmoking CessationBrainPerfusionBehavioralSmokerDopamine TransporterCessation Of LifeCandidate Disease GeneAddictionCue ReactivitySmoking BehaviorResponseRewardsExhibitsInsula Of ReilDesignCravingGenesRelapseLinkTreatment Strategy

Grant awards (21)

Influence of the natural hormonal milieu on perfusion fMRI smoking cue responses$504,427
R01 · FY2017 · DA · contact PI
Influence of the natural hormonal milieu on perfusion fMRI smoking cue responses$396,754
R01 · FY2016 · DA · contact PI
GABA B agonists revisited: Brain, behavioral and genetic effects in smokers$288,708
R01 · FY2016 · DA · contact PI
GABA B agonists revisited: Brain, behavioral and genetic effects in smokers$334,992
R01 · FY2015 · DA · contact PI
GABA B agonists revisited: Brain, behavioral and genetic effects in smokers$340,094
R01 · FY2014 · DA · contact PI
Characterizing a cue-vulnerable pharmaco-responsive endophenotype in smokers$268,496
R01 · FY2014 · DA · contact PI
Characterizing a cue-vulnerable pharmaco-responsive endophenotype in smokers$88,000
R01 · FY2014 · DA · contact PI
GABA B agonists revisited: Brain, behavioral and genetic effects in smokers$326,491
R01 · FY2013 · DA · contact PI
Characterizing a cue-vulnerable pharmaco-responsive endophenotype in smokers$260,594
R01 · FY2013 · DA · contact PI
Characterizing a cue-vulnerable pharmaco-responsive endophenotype in smokers$299,666
R01 · FY2012 · DA · contact PI
GABA B agonists revisited: Brain, behavioral and genetic effects in smokers$298,447
R01 · FY2012 · DA · contact PI
Characterizing a cue-vulnerable pharmaco-responsive endophenotype in smokers$304,557
R01 · FY2011 · DA · contact PI
DOPAMINERGIC VARIANTS INVOLVED IN SMOKING BEHAVIOR: A PERFUSION FMRI STUDY$7,688
P41 · FY2011 · RR · contact PI
Dopaminergic variants involved in smoking behavior: A perfusion fMRI study$155,925
R21 · FY2010 · DA · contact PI
DOPAMINERGIC VARIANTS INVOLVED IN SMOKING BEHAVIOR: A PERFUSION FMRI STUDY$8,672
P41 · FY2010 · RR · contact PI
Dopaminergic variants involved in smoking behavior: A perfusion fMRI study$189,000
R21 · FY2009 · DA · contact PI
Perfusion fMRI of cue-induced nicotine craving$115,273
K01 · FY2005 · DA
A PILOT TRIAL OF BACLOFEN FOR SMOKING REDUCTION$13,294
M01 · FY2005 · RR
Perfusion fMRI of Cue-Induced Nicotine Craving$111,915
K01 · FY2004 · DA
A Pilot Trial of Baclofen for Smoking Reduction$3,906
M01 · FY2004 · RR
Perfusion fMRI of Cue-Induced Nicotine Craving$108,654
K01 · FY2003 · DA